De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.
about
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Advances in antibiotic therapy in the critically illOptimizing antimicrobial therapy in critically ill patientsManagement of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French SRight first time!What's new in multidrug-resistant pathogens in the ICU?The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.Improving the Recognition of, and Response to In-Hospital Sepsis.Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis.Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferenceBloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcomeEvaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study.Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study.Treatment of bloodstream infections in ICUsCombatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program.How to treat severe infections in critically ill neutropenic patients?Agreement on the prescription of antimicrobial drugsYear in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill PatientsAdequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortalityDiagnostic performance of matrix-assisted laser desorption ionisation time-of-flight mass spectrometry in blood bacterial infections: a systematic review and meta-analysis.Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing.Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearanceFrequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans Healthcare AdministrationCharacteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infectionsBloodstream infections in the Intensive Care Unit.Bloodstream infections in neutropenic cancer patients: A practical update.ACVIM consensus statement on therapeutic antimicrobial use in animals and antimicrobial resistance.Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study.(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.Antimicrobial stewardship of β-lactams in intensive care units.Ventilator-associated pneumonia: present understanding and ongoing debates.Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting.The bacterial pneumonias: a new treatment paradigm.Evaluation of restricted antibiotic use in a hospital in Romania.Emerging commercial molecular tests for the diagnosis of bloodstream infection.Management of severe sepsis: advances, challenges, and current status.Rapid identification of pathogens in positive blood culture of patients with sepsis: review and meta-analysis of the performance of the sepsityper kit.Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).
P2860
Q26739860-6CE49E24-4FF5-473B-8F54-7073B030A67FQ26749328-9F7A9A6E-A1A2-4900-9B5A-BC8F1D69AA8DQ26999905-F674AA75-994A-44F9-B535-F434748DB5D4Q27320711-427508F9-55E9-4A3B-A672-CA976F26FEF3Q28067972-A7DF0095-C783-40B0-B84E-51E4BFC1C053Q28071346-475D2890-9F16-49FC-A580-ABD1DE28F334Q30238578-4E010757-987D-42FB-A52D-185F9A3F5DC3Q30250272-B14BC6B0-3DB2-4D42-9171-B661BB1700C7Q31171527-65D1A900-8ABE-42BA-8620-CB6FA5A38302Q33640559-96B9178A-A4E3-42A3-8604-4031F9411AD3Q33673654-BBC86DB7-3528-4492-8FC9-CFE4B552AEDAQ33846503-820C84F2-A92D-4722-BC1E-952F39093D62Q33925668-F87E0767-4F96-4B96-82DD-722FEA1B3251Q34896896-4D366FBC-CE18-44F4-9153-58E746DCDA9DQ35181034-F711D15D-131D-4C99-8DDE-F4C69D173627Q35457899-AAD39E59-8F24-411B-83AE-48610B33268DQ35677940-C2764733-5F3D-4921-A90C-EE790D63C28EQ35816268-6A96F8B8-568E-46E6-91F5-D89786FF4847Q35860038-02AB86C0-8430-4505-AEA7-D42E730AF689Q35996888-5E458858-2CDE-465A-9170-5DA7D429148EQ36000312-31B7728D-0F62-4085-BFD0-489B5D4D7D61Q36030480-502945B9-988C-405E-A319-98C1BB34EBE6Q36089167-F4A77D72-CEBC-41B6-B929-199055946C74Q36220740-CFBABB6F-91E1-4B9A-AFF3-DDF7C1F99259Q36455347-79BEE873-33B1-4945-9134-7BA866224AFAQ36774787-83C2B0B4-D090-463A-99E7-AD6EC8BAF278Q36913336-E388C425-51FC-4894-81C7-840345BEAA38Q36913345-48E83B58-F720-4409-BADB-F813CD37C56DQ36975171-35741558-A480-4806-8720-8A089846C743Q37132283-94050A65-4A35-4E12-92CE-F8C785E3BD28Q37225323-5376CB54-209C-48AF-9A63-80BD64774367Q38198157-06CB6701-B324-411F-9625-11E63361200CQ38271775-75F34555-1F76-410F-A1A2-B4EBFF598C7AQ38282826-F46FCAD5-D32F-43D9-95BE-364E915D55CCQ38307688-62D5553A-9D2A-46C3-8265-60353AE0C493Q38400333-5F1AEBD9-7085-4D71-80C2-4F2A1BA7E3FCQ38417636-44E264EA-20AF-457A-B0E9-EE3B27CB3BC5Q38450665-B51AC40F-A2E5-4FE7-BCE1-D55960D88039Q38497276-5EC19C1D-4244-4ED1-A544-22F82EF670D8Q38528292-61B59E8A-A7A2-4276-BA9F-5406225074C3
P2860
De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
De-escalation of empirical the ...... evere sepsis and septic shock.
@en
De-escalation of empirical the ...... evere sepsis and septic shock.
@nl
type
label
De-escalation of empirical the ...... evere sepsis and septic shock.
@en
De-escalation of empirical the ...... evere sepsis and septic shock.
@nl
prefLabel
De-escalation of empirical the ...... evere sepsis and septic shock.
@en
De-escalation of empirical the ...... evere sepsis and septic shock.
@nl
P2093
P1476
De-escalation of empirical the ...... severe sepsis and septic shock
@en
P2093
A Escoresca-Ortega
C Ortiz-Leyba
Esperanza Fernández-Delgado
I Herrera-Melero
J A Márquez-Vácaro
Y Corcia-Palomo
P2888
P356
10.1007/S00134-013-3077-7
P577
2013-09-12T00:00:00Z